Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Builds Manpower for Business Development

NEW YORK, June 20 - Large Scale Biology has expanded its business development team, creating two new executive positions, the company said Wednesday. 

Pieter Bax, who joined LSBC earlier this year, will serve as senior vice president for corporate development, and Guy della-Cioppa, formerly vice president for genomics, will serve as vice president for business development.

In addition, Manfred Scholz recently joined the company as senior director for business development.

LSBC said in a statement that the new appointments were geared to drumming up awareness of the company's technology and to encouraging new partnerships.

Before joining LSBC, Bax served as vice president of the biopharmaceutical development division of SRI International, a consulting firm, and previously worked as vice president for business development and product planning at Corvas International, a biotechnology firm based in San Diego.

Della-Cioppa has served as vice president for genomics at LSBC since 1989. During his tenure, he managed LSBC's business relationship with Dow Chemical and Dow AgroSciences, and in his new business development position, he will focus on establishing new business alliances, the company said.

Scholz will be located at LSBC's proteomics facility in Germantown, Md. Prior to joining LSBC, he worked at Boston Medical Consultants, where he provided strategic planning and market forecasting for in vitro diagnostics, histopathology, SNP genotyping and other genomics and proteomics companies.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more